Who makes Travesol 10%?

Travesol 10% is developed by Milton S. Hershey Medical Center.

What development phase is Travesol 10% in?

Travesol 10% is FDA-approved (marketed).

Last reviewed 2026-05-13 · How we verify

Travesol 10%

Milton S. Hershey Medical Center · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Travesol 10%
Sponsor	Milton S. Hershey Medical Center
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Amino Acid Infusion in Cardiac Surgery (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Travesol 10% CI brief — competitive landscape report
Travesol 10% updates RSS · CI watch RSS
Milton S. Hershey Medical Center portfolio CI